AR116635A1 - Proceso para la síntesis de derivados de piperazinil-etoxi-bromofenilo y su aplicación en la producción de compuestos que los contienen - Google Patents
Proceso para la síntesis de derivados de piperazinil-etoxi-bromofenilo y su aplicación en la producción de compuestos que los contienenInfo
- Publication number
- AR116635A1 AR116635A1 ARP190102897A ARP190102897A AR116635A1 AR 116635 A1 AR116635 A1 AR 116635A1 AR P190102897 A ARP190102897 A AR P190102897A AR P190102897 A ARP190102897 A AR P190102897A AR 116635 A1 AR116635 A1 AR 116635A1
- Authority
- AR
- Argentina
- Prior art keywords
- bromophenil
- piperazinil
- etoxy
- synthesis
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic System
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
Abstract
Reivindicación 1: Un proceso para preparar un compuesto de fórmula (1), en donde: R¹ y R² independientemente uno de otro representan un átomo de halógeno, un grupo alquilo C₁₋₆ lineal o ramificado, un grupo alcoxi C₁₋₆ lineal o ramificado, un grupo alcoxi C₁₋₆alcoxi C₁₋₆ lineal o ramificado, un grupo hidroxilo o un grupo ciano; R³ representa un grupo alquilo C₁₋₆ lineal o ramificado, que comprende la etapa de hacer reaccionar un compuesto de fórmula (2), en donde R¹ y R² son como se han definido anteriormente, con un compuesto de fórmula (3), en donde R³ es como se ha definido anteriormente, y X⁻ representa un contraión aniónico monovalente, en un disolvente, a alta temperatura en presencia de una base.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18306354 | 2018-10-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR116635A1 true AR116635A1 (es) | 2021-05-26 |
Family
ID=63965576
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP190102897A AR116635A1 (es) | 2018-10-15 | 2019-10-11 | Proceso para la síntesis de derivados de piperazinil-etoxi-bromofenilo y su aplicación en la producción de compuestos que los contienen |
Country Status (15)
Country | Link |
---|---|
US (1) | US11512062B2 (es) |
EP (1) | EP3867233A1 (es) |
JP (1) | JP7448532B2 (es) |
KR (1) | KR20210076094A (es) |
CN (1) | CN112930340A (es) |
AR (1) | AR116635A1 (es) |
AU (1) | AU2019362310A1 (es) |
BR (1) | BR112021006467A2 (es) |
CA (1) | CA3115608A1 (es) |
EA (1) | EA202190989A1 (es) |
IL (1) | IL282094A (es) |
MA (1) | MA53897A (es) |
MX (1) | MX2021004288A (es) |
TW (1) | TW202033506A (es) |
WO (1) | WO2020078875A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW202315637A (zh) | 2021-06-11 | 2023-04-16 | 美商基利科學股份有限公司 | Mcl-1抑制劑與抗癌劑之組合 |
KR20240019330A (ko) | 2021-06-11 | 2024-02-14 | 길리애드 사이언시즈, 인코포레이티드 | Mcl-1 저해제와 항체 약물 접합체의 조합 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4401824A (en) * | 1982-03-08 | 1983-08-30 | The Upjohn Company | Benzopyran compounds, derivatives of prostaglandins |
US6867203B2 (en) * | 1998-12-29 | 2005-03-15 | Abbott Laboratories | Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
GB0500029D0 (en) | 2005-01-04 | 2005-02-09 | Univ Belfast | Basic ionic liquids |
US7759337B2 (en) | 2005-03-03 | 2010-07-20 | Amgen Inc. | Phthalazine compounds and methods of use |
US20090099186A1 (en) * | 2005-10-11 | 2009-04-16 | Leonid Beigelman | Inhibitors of viral replication |
TW201107302A (en) | 2009-06-26 | 2011-03-01 | Glaxo Group Ltd | Compounds |
CA2778175A1 (en) * | 2009-11-11 | 2011-05-19 | Yoshihiro Horiuchi | 8-azabicyclo[3.2.1]octane-8-carboxamide derivative |
ES2749910T3 (es) | 2011-06-17 | 2020-03-24 | Nantenergy Inc | Celda electroquímica que comprende un aditivo heteroiónico |
TWI464242B (zh) * | 2012-10-26 | 2014-12-11 | Ind Tech Res Inst | 負介電異方性液晶化合物、液晶顯示器、與光電裝置 |
KR102006994B1 (ko) * | 2013-03-28 | 2019-08-02 | 주식회사 삼양사 | 신규 페난트렌 화합물, 이의 제조방법 및 이를 이용한 유기전자소자 |
WO2015024203A1 (en) | 2013-08-20 | 2015-02-26 | Leo Pharma A/S | Novel neurokinin 1 receptor antagonist compounds ii |
FR3015483B1 (fr) | 2013-12-23 | 2016-01-01 | Servier Lab | Nouveaux derives de thienopyrimidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
WO2015162515A1 (en) | 2014-04-25 | 2015-10-29 | Pfizer Inc. | Heteroaromatic compounds and their use as dopamine d1 ligands |
EP3151833A4 (en) | 2014-06-04 | 2018-01-10 | Thomas Helledays Stiftelse För Medicinsk Forskning | Mth1 inhibitors for treatment of inflammatory and autoimmune conditions |
FR3037959B1 (fr) | 2015-06-23 | 2017-08-04 | Servier Lab | Nouveaux derives bicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR3037956B1 (fr) * | 2015-06-23 | 2017-08-04 | Servier Lab | Nouveaux derives d'acide amine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR3037958B1 (fr) | 2015-06-23 | 2019-01-25 | Les Laboratoires Servier | Nouveaux derives d'hydroxy-acide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR3046792B1 (fr) | 2016-01-19 | 2018-02-02 | Les Laboratoires Servier | Nouveaux derives d'ammonium, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
WO2017180571A1 (en) | 2016-04-11 | 2017-10-19 | Janssen Pharmaceutica Nv | Substituted benzothiophenyl derivatives as gpr40 agonists for the treatment of type ii diabetes |
KR101891263B1 (ko) * | 2016-07-20 | 2018-08-23 | 주식회사 엘지화학 | 신규한 헤테로고리 화합물 및 이를 포함하는 유기발광 소자 |
SG11201903326RA (en) * | 2016-10-28 | 2019-05-30 | Servier Lab | Liposomal formulation for use in the treatment of cancer |
CN107573360B (zh) | 2017-10-27 | 2019-08-09 | 都创(上海)医药科技有限公司 | 一种多靶点小分子化合物s63845的制备方法 |
-
2019
- 2019-10-11 AR ARP190102897A patent/AR116635A1/es unknown
- 2019-10-14 CA CA3115608A patent/CA3115608A1/en active Pending
- 2019-10-14 EA EA202190989A patent/EA202190989A1/ru unknown
- 2019-10-14 JP JP2021520367A patent/JP7448532B2/ja active Active
- 2019-10-14 BR BR112021006467-2A patent/BR112021006467A2/pt unknown
- 2019-10-14 TW TW108136946A patent/TW202033506A/zh unknown
- 2019-10-14 EP EP19784071.3A patent/EP3867233A1/en active Pending
- 2019-10-14 CN CN201980067808.2A patent/CN112930340A/zh active Pending
- 2019-10-14 AU AU2019362310A patent/AU2019362310A1/en active Pending
- 2019-10-14 US US17/283,107 patent/US11512062B2/en active Active
- 2019-10-14 WO PCT/EP2019/077729 patent/WO2020078875A1/en unknown
- 2019-10-14 KR KR1020217014515A patent/KR20210076094A/ko active Search and Examination
- 2019-10-14 MX MX2021004288A patent/MX2021004288A/es unknown
- 2019-10-14 MA MA053897A patent/MA53897A/fr unknown
-
2021
- 2021-04-06 IL IL282094A patent/IL282094A/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA3115608A1 (en) | 2020-04-23 |
JP7448532B2 (ja) | 2024-03-12 |
WO2020078875A1 (en) | 2020-04-23 |
US11512062B2 (en) | 2022-11-29 |
EA202190989A1 (ru) | 2021-07-05 |
US20210380549A1 (en) | 2021-12-09 |
EP3867233A1 (en) | 2021-08-25 |
JP2022512694A (ja) | 2022-02-07 |
TW202033506A (zh) | 2020-09-16 |
CN112930340A (zh) | 2021-06-08 |
AU2019362310A1 (en) | 2021-05-13 |
KR20210076094A (ko) | 2021-06-23 |
BR112021006467A2 (pt) | 2021-07-13 |
IL282094A (en) | 2021-05-31 |
MA53897A (fr) | 2022-01-19 |
MX2021004288A (es) | 2021-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR114631A1 (es) | Métodos e intermedios para preparar compuestos de piridina | |
DOP2015000239A (es) | Derivados de 1-acil-4-amino-1,2,3,4-tetrahidroquinolina 2,3-disustituidos y su uso como inhibidores del bromodominio | |
AR116635A1 (es) | Proceso para la síntesis de derivados de piperazinil-etoxi-bromofenilo y su aplicación en la producción de compuestos que los contienen | |
AR098906A1 (es) | Derivados de tienopirimidina, un proceso para su preparación y composiciones farmacéuticas que los contienen | |
CY1123154T1 (el) | Παραγοντας ενισχυσης της επιδρασης αποκαταστασης μετα απο νευρικη βλαβη που περιλαμβανει ενα παραγωγο αλκυλαιθερα ή ενα αλας αυτου | |
AR088829A1 (es) | DERIVADOS DE CICLOHEXILAMINA QUE TIENEN ACTIVIDAD COMO AGONISTAS ADRENERGICOS b2 Y COMO ANTAGONISTAS MUSCARINICOS M3 | |
AR049401A1 (es) | Aza-biciclononanos | |
AR119493A1 (es) | Derivados de 3,6-diamino-piridazin-3-ilo, composiciones farmacéuticas que los contienen y sus usos como agentes proapoptóticos | |
BR112019007980A2 (pt) | método para produzir 3-alquilsulfanil-2-cloro-n-(1-alquil-1h-tetrazol-5-il)-4-trifluorometil-benzamidas | |
AR109735A1 (es) | Método para la síntesis de derivado de 3-fenil-2,3,4,8,9,10-hexahidropirano[2,3-f]cromeno e isómero óptico del mismo | |
AR107549A1 (es) | Un proceso para preparar compuesto de pirrolo[3,2-d]pirimidina y su intermediario | |
AR103742A1 (es) | Derivados de trifluorometilpropanamida | |
AR113842A1 (es) | Derivados de tiazol microbiocidas | |
CL2022002255A1 (es) | Compuestos heterocíclicos de heteroarilo y usos de los mismos | |
AR088816A1 (es) | Proceso para preparar derivados de 1-acil-4-fenilsulfonilprolinamida y compuestos intermediarios | |
BR112021026899A2 (pt) | Compostos heterocíclicos | |
AR101798A1 (es) | Quinolinas herbicidas | |
CY1107034T1 (el) | ΜΕΘΟΔΟΣ ΠΑΡΑΣΚΕΥΗΣ Ν-ΜΟΝΟΫΠΟΚΑΤΕΣΤΗΜΕΝΩΝ β-ΑΜΙΝΟ ΑΛΚΟΟΛΩΝ | |
BR112013016637A2 (pt) | processo para a preparação de derivados de 3-alquil-sulfinilbenzoíla | |
AR091499A1 (es) | Derivados de pirimidinonas, su preparacion y su aplicacion en terapeutica | |
BR0212982A (pt) | Processo para preparar um composto, e, composto | |
GB1029228A (en) | A method of preparing new quaternary ammonium salts with disinfectant activity | |
MX3057E (es) | Proceso para la preparacion de anilidas heterociclicas | |
AR117504A1 (es) | Proceso para la preparación de antranilamidas | |
AR111897A1 (es) | Compuestos de piridina y pirazina |